RE: Recent info posts2 Dec 2018 08:57
Thanks babbler. Yes I agree with the IP, but my only concern here currently is the timeframe to turn any commercial transaction into revenue, to avoid any fundraising. I assume we don’t have actual details on the commercial side of the ANobel deal yet? Ultimately this IP won’t be creating revenue to level needed, hopefully as you say the IP and name we are associated with may well add value and future value of the product so any raise would (if needed) be at a higher SP. I juts have a feeling the AN deal is a bit of a red heron and some are getting carried away with the uplift in SP, which again, I do feel a good part has already been factored in, given the recent rises. But this is aim, so let’s see